Recombinant Rat Nos3 Protein ，His

NOS3, or endothelial nitric oxide synthase (eNOS), is a critical enzyme responsible for the production of nitric oxide (NO) in endothelial cells, which plays a vital role in vascular homeostasis and function. Research into NOS3 has gained significant attention due to its implications in various cardiovascular diseases, including hypertension, atherosclerosis, and heart failure. Dysregulation of NO production can lead to endothelial dysfunction, a key factor in the pathogenesis of these conditions. Recombination proteins of NOS3 are engineered to study the enzyme's structure-function relationship and to explore the molecular mechanisms underlying its regulation and activity. The production of NOS3 recombinant proteins allows for detailed biochemical analyses, enabling researchers to investigate how different post-translational modifications and interactions with other proteins affect its functionality. These studies not only contribute to understanding the physiological role of NOS3 in maintaining vascular health but also hold potential therapeutic implications. By targeting NOS3 or its pathways, novel treatments could be developed to ameliorate cardiovascular diseases associated with NO deficiency or endothelial dysfunction. As interest in personalized medicine grows, the exploration of NOS3 and its recombinant forms continues to be a relevant and promising area of research, particularly in the context of designing targeted therapies aimed at restoring endothelial function.